Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kea Martin

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Immunology|May 20, 2020
Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like PathologyKea Martin, Ursula Junker, Elaine Tritto, et al.
Journal for Immunotherapy of Cancer|July 14, 2026
Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunityNicole Oelgarth, Kea Martin, Fabian Junker, et al.
Cell Reports|September 26, 2019
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor ResponsesAbhishek S Kashyap, Laura Fernandez-Rodriguez, Yun Zhao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2020
Requirement of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Protease Activity for Fcγ Receptor-Induced Arthritis, but Not Fcγ Receptor-Mediated Platelet Elimination, in MiceKea Martin, Ratiba Touil, Grozdan Cvijetic, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Immunology|May 20, 2020
Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like PathologyKea Martin, Ursula Junker, Elaine Tritto, et al.
Journal for Immunotherapy of Cancer|July 14, 2026
Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunityNicole Oelgarth, Kea Martin, Fabian Junker, et al.
Cell Reports|September 26, 2019
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor ResponsesAbhishek S Kashyap, Laura Fernandez-Rodriguez, Yun Zhao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2020
Requirement of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Protease Activity for Fcγ Receptor-Induced Arthritis, but Not Fcγ Receptor-Mediated Platelet Elimination, in MiceKea Martin, Ratiba Touil, Grozdan Cvijetic, et al.
Pageof 2